How Much Did Impilo Raise?
Funding & Key Investors

Impilo, a digital health device platform company, has secured a major strategic investment as part of its recent funding round, bringing its total capital raised to $11.5M. The company announced its latest financing event, valued at $11.5M, on November 14, 2024. This significant capital infusion underscores the growing investor confidence in Impilo's innovative approach to managing digital health device operations.

What is Impilo?

Impilo
SoftwareHealthcare Software

Founded in 2020 and headquartered in Philadelphia, PA, Impilo operates within the burgeoning digital health sector. The company's core offering is a sophisticated platform designed to streamline the entire lifecycle of digital health devices for its clientele. This includes facilitating the purchase, distribution, support, and integration of these devices. Impilo provides essential API infrastructure, enabling healthcare stakeholders to automate and optimize their device supply chain operations, thereby enhancing efficiency and accessibility in digital healthcare.

How much funding has Impilo raised?

Impilo has raised a total of $11.5M across 1 funding round:

2024

Series A

$11.5M

Series A (2024): $11.5M with participation from GC 1 Capital, One Way Ventures, and Construct Capital

Key Investors in Impilo

GC 1 Capital

GC 1 Capital is an investor participating in the funding round for Impilo. Further details regarding their investment focus are not publicly available.

One Way Ventures

One Way Ventures is a venture capital firm dedicated to supporting immigrant founders in building high-impact global companies. They invest in exceptional startups and aim to foster opportunities irrespective of a founder's birthplace.

Construct Capital

Construct Capital is a veteran-owned business based in Arlington, Texas, that oversees companies in the foundation repair and plumbing sectors. Their investment in Impilo suggests an interest in innovative operational infrastructure.

What's next for Impilo?

With the recent major enterprise-level funding, Impilo is strategically positioned for accelerated growth and market expansion. The company's focus on automating digital health device supply operations addresses a critical need within the healthcare industry. This latest capital injection will likely fuel further development of its API infrastructure, enhance its market reach, and potentially support strategic partnerships. Impilo's trajectory suggests a move towards scaling its operations to meet the increasing demand for integrated digital health solutions.

See full Impilo company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Enterprise Resource Planning (ERP)SoftwareBusiness Intelligence (BI) Software
Financial SoftwareSoftwareSupply Chain Management (SCM) Software
Content & Collaboration SoftwareSoftwareEducationTraining
Financial SoftwareSoftwareMobile App Development

Frequently Asked Questions Regarding Impilo Financial Insights

What are the most recent funding rounds that Impilo has completed, and what were the funding rounds?
Impilo has recently completed 1 funding rounds: Series A on Nov 14, 2024.
What is the total amount of funding Impilo has raised to date?
Impilo has raised a total of $11.5M in funding to date.
How many funding rounds has Impilo completed?
Impilo has completed 1 funding rounds.
How much funding did Impilo raise in its most recent funding round?
Impilo raised $11.5M in its most recent funding round.
Who are the lead investors in Impilo's latest funding round?
The lead investor in Impilo's latest funding round was GC 1 Capital. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Impilo's history?
The largest funding round in Impilo's history was $11.5M.
See more information about Impilo